Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locoregionally-advanced Oropharyngeal Squamous Cell Carcinoma”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)WithdrawnNCT03423264
What this trial is testing

PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

Who this might be right for
Oropharyngeal CancerHPV-Related Squamous Cell Carcinoma
University of Chicago
Large-scale testing (Phase 3)UnknownNCT01855451
What this trial is testing

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Trans Tasman Radiation Oncology Group 189
Testing effectiveness (Phase 2)Study completedNCT02254278
What this trial is testing

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

Who this might be right for
Stage III Oropharyngeal Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell Carcinoma+2 more
NRG Oncology 316
Testing effectiveness (Phase 2)Looking for participantsNCT06219980
What this trial is testing

SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx

Who this might be right for
SBRT
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05639972
What this trial is testing

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Who this might be right for
HPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more
Christian Hinrichs 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861712
What this trial is testing

Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Stereotactic Body Radiation Therapy (SBRT)
Sun Yat-sen University 50
Not applicableStudy completedNCT03838601
What this trial is testing

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03410615
What this trial is testing

Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Canadian Cancer Trials Group 129
Large-scale testing (Phase 3)Temporarily pausedNCT05050162
What this trial is testing

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+7 more
NRG Oncology 1,714
Early research (Phase 1)Study completedNCT01540682
What this trial is testing

MLN8237 in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Abramson Cancer Center at Penn Medicine 9
Testing effectiveness (Phase 2)Study completedNCT01711541
What this trial is testing

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaStage IVA Oropharyngeal Carcinoma AJCC v7Stage IVB Oropharyngeal Carcinoma AJCC v7
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT03759730
What this trial is testing

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locoregionally-advanced Oropharyngeal Squamous Cell Carcinoma
University Health Network, Toronto 26
Testing effectiveness (Phase 2)Study completedNCT03107182
What this trial is testing

Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer

Who this might be right for
HPV-Related Squamous Cell CarcinomaHNSCC
University of Chicago 72
Testing effectiveness (Phase 2)UnknownNCT01516996
What this trial is testing

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

Who this might be right for
Oropharyngeal CancerHypopharyngeal Cancer
The Second People's Hospital of Sichuan 80
Testing effectiveness (Phase 2)Looking for participantsNCT06648096
What this trial is testing

Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Fanconi AnemiaHead and Neck Squamous Cell Carcinoma
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Large-scale testing (Phase 3)Study completedNCT03258554
What this trial is testing

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+17 more
National Cancer Institute (NCI) 196
Early research (Phase 1)Study completedNCT02381535
What this trial is testing

Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin

Who this might be right for
Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more
National Cancer Institute (NCI) 2